ATI-1777, a Topical Jak1/3 Inhibitor, May Benefit Atopic Dermatitis without Systemic Drug Exposure: Results from Preclinical Development and Phase 2a Randomized Control Study ATI-1777-AD-201
Titel:
ATI-1777, a Topical Jak1/3 Inhibitor, May Benefit Atopic Dermatitis without Systemic Drug Exposure: Results from Preclinical Development and Phase 2a Randomized Control Study ATI-1777-AD-201
Auteur:
Changelian, Paul Xu, Canxin Mnich, Steve Hope, Heidi Kostecki, Kourtney Hirsch, Jeff Loh, Chin-Yi Anderson, David Blinn, James Hockerman, Susan Dick, Evan Smith, Walter Monahan, Joseph Raoof, Tooraj Forman, Seth Burt, David Barnes, Brad Gordon, David Walker, Neal Sudzina, John Tucker, Stephen Jacobsen, Jon